GarrieJHaasMD
Cardiology • Columbus, OHAdult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation
Professor, Internal Medicine, Ohio State University College of Medicine
Dr. Haas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 W 10th Ave
Columbus, OH 43210Phone+1 614-293-4967Fax+1 614-293-5614
Education & Training
Ohio State University HospitalFellowship, Cardiovascular Disease, 1986 - 1989- Ohio State University HospitalResidency, Internal Medicine, 1983 - 1986
Marshall University Joan C. Edwards School of MedicineClass of 1983
Certifications & Licensure
OH State Medical License 1985 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients Start of enrollment: 2006 Jun 01
- A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
- Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 672 citationsUltrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.Maria Rosa Costanzo, Maya Guglin, Mitchell T. Saltzberg, Mariell Jessup, Bradley A. Bart
Journal of the American College of Cardiology. 2007-02-13 - 138 citationsAquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure.Maria Rosa Costanzo, Daniel Negoianu, Brian E. Jaski, Bradley A. Bart, J.T. Heywood
JACC. Heart Failure. 2016-02-01 - 45 citationsA Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with ...Cristina Tita, Edward M. Gilbert, Adrian B. Van Bakel, Jacek Grzybowski, Garrie J. Haas
European Journal of Heart Failure. 2017-07-05
Press Mentions
V-wave Launches Pivotal Interatrial Shunt TrialOctober 3rd, 2018
Ohio State First in U.S. To Test Shunt Device for Heart FailureSeptember 25th, 2018
ABIM Announces New Specialty Board and Exam Committee MembersJuly 10th, 2018- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
